Handbooks

ESH Handbooks

ESH believes it is very important to allow specialists to gain new knowledge, competencies, and skills or to brush up on acquired ones at a time and place of their choosing. At certain points in their careers, it may be more difficult for specialists to attend live events because of time, mobility, financial or other restraints. Or they may simply wish to review content presented at a session they attended. ESH Handbooks are intended as an important compliment to live formats. By combining multiple learning payhways (“blended learning”) ESH is currently expanding on its online education and training in the aim of improving access to high quality peer-reviewed education and training:

Handbooks:

1. ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation (2012)
2. ESH Handbook on Immune Thrombocytopenia (2010)
3. ESH Handbook on Disorders of Erythropoiesis, Erythrocytes and Iron Metabolism (2009)
4. ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation (2008)
5. ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation (2004 out of print)
6. ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation (1999 out of print)
7. ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation (1998 out of print)

ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation 2012

2012/02/29

By J. Apperley, E. Carreras, E. Gluckman, T. Masszi

Responses to Multiple Choice Questions can be found here

ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation 2012

Editors: J. Apperley, E. Carreras, E. Gluckman, T. Masszi

To order your copy, please complete the online request form.

ESH Handbook on Immune Thrombocytopenia (2010)

2012/02/23

By Douglas B. Cines, David J. Kuter, Andrian C. Newland, Drew Provan, John W. Semple

Responses to Multiple Choice Questions can be found here

The first edition of the ITP Handbook.

To access the online version please click here

Please note that: you will be asked to cover the delivery charges. There will be a delay for the delivery of two to three weeks after the receipt of payment.

If you want to reserve a copy, please fill in the request form Supported by an educational grant from

A multiple choice questionaire can be found at the end of each chapter of the Handbook 2010. To access the correct answers to these questionaires please click here.

ESH Handbook on Disorders of Iron Metabolism

ESH Handbook on Disorders of Erythropoiesis, Erythrocytes and Iron Metabolism (2009)

ESH - Club du Globule Rouge et du Fer Handbook on
Disorders of Iron Homeostasis, Erythrocytes and Erythropoiesis
Editors: Carole Beaumont, Photis Béris, Yves Beuzard, Carlo Brugnara.

Thanks to educational grants from the following ESH Bronze Institutional Partners:

The Iron Handbook

	The 2009 revised edition of the Handbook on Disorders of Erythropoiesis, Erythrocytes and Iron Metabolism Editors: Carole Beaumont, Photis Béris, Yves Beuzard, Carlo Brugnara

The 2009 revised edition of the Handbook on Disorders of Erythropoiesis, Erythrocytes and Iron Metabolism

Editors: Carole Beaumont, Photis Béris, Yves Beuzard, Carlo Brugnara

The Iron Handbook (2009 edition) is now also available online.

Click here to access to the Handbook Questions.

Click on the title of each chapter to view and download in .pdf format.

Websites of Interest
Chapter	Author/s
1. Regulation of oxygen sensing and erythropoietin production	P.H. Maxwell, C.W. Pugh
2. Regulation of erythropoiesis	J. Vandekerckhove, G. Courtois, S. Coulon, J.-A. Ribeil, O. Hermine
3. Red blood cells: proteomics, physiology and metabolism	E.M. Pasini, A.W. Thomas, M. Mann
4. Pathophysiology and differential diagnosis of anaemia	J.-F. Lambert, Ph. Beris
5. Diamond-Blackfan anaemia, a constitutional erythroblastopenia	L. Da Costa, G. Tchernia, Th. Leblanc
6. Aplastic anaemia	Ph. Scheinberg, N.S. Young
7. Congenital dyserythropoietic anaemias	H. Heimpel, A. Iolascon
8. Familial and acquired polycythaemia
8.1. Familial polycythaemia	J. Prchal, V. Gordeuk
8.2. Acquired polycythaemia	Ch. James, W. Vainchenker
9. Treatment with erythropoiesis stimulating agents	N. Casadevall
10. Molecular basis of thalassaemia syndromes	B. Wood, D. Higgs
11. Management of thalassaemia	R. Galanello, R. Origa
12. Thalassaemia intermedia	M.D. Cappellini, K.M. Musallam, C. Cesaretti, A. Taher
13. Sickle cell disease
13.1. Pathophysiology and target pathways for novel therapies	L. De Franceschi, C. Brugnara
13.2. A short guide to management	F. Galactéros, M. de Montalembert
14. Haematopoietic stem cell transplantation
14.1. For patients with thalassaemia	F. Locatelli, M.E. Bernardo
14.2. In patients with sickle cell anaemia	F. Bernaudin, E. Gluckman
15. First human gene therapy trial for haemoglobin disorders	E. Payen, O. Nègre, B. Gillet-Legrand, Y. Beuzard, E. Gluckman, Ph. Leboulch
16. Disorders of the red cell membrane	J. Delaunay, J.-P. Cartron
17. Red blood cell enzyme defects	J.-L. Vives Corrons
18. Red blood cells and malaria	N. Mohandas, X. An
19. Iron and erythropoiesis	S. Millot, L. de Falco, C. Beaumont
20. Iron homeostasis	C. Beaumont, S. Vaulont
21. Iron therapy	C. Brugnara, Ph. Beris
22. Sideroblastic anaemias	N. Gattermann, Ph. Beris
23. Diagnosis and treatment of HFE-haemochromatosis	P. Brissot, C. Le Lan, M.-B. Troadec, M. Ropert, F. Gaboriau, G. Lescoat, A.-M. Jouanolle, F. de Bels, O. Loréal
24. Diagnosis and treatment of non-HFE-haemochromatosis	C. Camaschella
25. Evaluation and treatment of secondary iron overload	A. Piga, S. Roggero, F. Longo, O. Ernst, Ch. Rose
26. Anaemia in the elderly	E.A. Price
27. Haem biosynthesis and the porphyrias	J.-Ch. Deybach, L. Gouya, H. Puy
Abbreviations

ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation (2008)

The 2008 revised edition of the EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation

Editors: J. Apperley, E. Carreras, E. Gluckman, A. Gratwohl, T. Masszi

To reserve a copy, please fill in the request form by clicking here.

The ESH-EBMT Handbook (2008 edition) is now also available online.

Click on the title of each chapter to view and download in .pdf format.

To find the anwers to the Multiple Choice Questions, please click here.

Chapter	Author/s
1. Stem cell transplant organisations	J. Apperley, A. Keating
2. Biological properties of haematopoietic stem cells	A. Wodnar-Filopowicz
3. Immunogenetics of allogeneic HSCT
3.1. The role of HLA in HSCT	J.M. Tiercy
3.2. KIR: Beneficial effects of natural killer cell alloreactivity in haploididentical HSCT	A. Velardi, A. Mancusi, F. Aversa, M.F. Martelli
3.3. Non-HLA immunogenetics and role in transplant outcome	A.M. Dickinson
4. JACIE accreditation of transplant centres	D. Samson
5. Sources and procurement of stem cells	J. Larghero, J. García, E. Gluckman
6. Principles of conditioning	A. Gratwohl
7. Transfusion policy	D.H. Pamphilon
8. Supportive care	T. Masszi
9. Early complications after HSCT	E. Carreras
10. Infections after HSCT	C. Cordonnier
11. Graft versus host disease	A. Devergie
12. Long term survivorship, general health status, quality of life and late complications after HSCT	A. Tichelli, C-P. Schwarze, G.Socié
13. The value of molecular monitoring in haematological malignancy; minimal residual disease (MRD), relapse and chimerism	S.R. McCann, M. Lawler
14. Immunotherapy post-transplant
14.1. Immunotherapy post-transplant for infections	M. Kapp, G.U. Grigoleit, H. Einsele
14.2. Adoptive cellular immunotherapy to harness post-transplant alloreactivity	E. Nadal
15. Immune reconstitution after allogeneic HSCT	A. Toubert
16. Psychosocial aspects of HSCT	A. Kiss
17. Indications and current practice for allogeneic and autologous HSCT for haematological diseases, solid tumours and immune disorders	A. Gratwohl, P.Ljungman
18. Statistical evaluation of HSCT data	R.M. Szydlo
19. Methodology of conducting academic clinical trialsin Europe	Z. Doran
20. HSCT for acute myeloid leukaemia in adults	R. Varaldo, F. Frassoni
21. HSCT for acute lymphoblastic leukaemia in adults	N. Gökbuget, D. Hoelzer
22. HSCT for myelodysplasia in adults	T. de Witte, G. Sanz
23. HSCT for chronic myeloid leukaemia in adults	D. Niederweiser
24. HSCT for myeloproliferate disorders in adults	P. Guardiola
25. HSCT for chronic lymphocytic leukaemia in adults	P. Dreger
26. HSCT for multiple myeloma in adults	J.A. Pérez-Simon, J. San Miguel
27. HSCT for primary amyloidosis in adults	J. Esteve
28. HSCT for high-grade non-Hodgkin's lymphoma in adults	A. Johnston, B. Coiffier
29. HSCT for low-grade non-Hodgkin's lymphoma in adults	J.G. Cribben
30. HSCT for Hodgkin's lymphoma in adults	A. Sureda
31. HSCT for solid tumours in adults	M. Bregni
32. HSCT for autoimmune diseases in adults	R. Saccardi, D. Farge
33. HSCT for aplastic anaemia in adults	J. Passweg, A. Bacigalupo, A. Locasciulli
34. HSCT for tissue regeneration in adults	F. Prosper
35. HSCT for acute myeloid leukaemia in children	G. Dini, M. Miano
36. HSCT for acute lymphoblastic leukaemia in children	T. Klingebiel, P. Bader
37. HSCT for myelodysplastic syndromes in children	F. Locatelli, C.M. Niemeyer
38. HSCT for chronic myeloproliferate disorders in children	F. Locatelli, P. Merli
39. HSCT for lymphomas in children	M. Miano, G. Dini
40. HSCT for children with severe combined immunodificiencies (SCID)	M. Cavazzana-Calvo, W. Friedrich, A. Fischer
41. HSCT for inborn errors of metabolism	J.J. Boelens, R.F. Wynn, M. Bierings
42. HSCT for hereditary bone marrow failure syndromes	E. Gluckman, J.E. Wagner
43. HSCT in the haemoglobinopathies	I.A.G. Roberts, J. de la Fuente
Abbreviations
Appendix: EBMT Officers, Coordination Offices, Committees, Working Parties, Nurses Group Board, Affiliated Organisations/Websites

The ESH-EBMT Handbook is supported

by an unrestricted educational grant

from Chugai Sanofi Aventis

Email
Password
Forgot your password?